User:Mr. Ibrahem/Obiltoxaximab

Obiltoxaximab, sold under the brand name Anthim, is a medication used to treat and prevent anthrax. It is used together with antibiotics for cases affecting the lungs. It is given by gradual injection into a vein.

Common side effects include headache, itchiness, upper respiratory tract infection, and pain at the site of injection. Other side effects may include anaphylaxis. While there has not be found to be harm in pregnancy, such use has not been well studied. It is a monoclonal antibody which binds to the Bacillus anthracis toxin.

Obiltoxaximab was approved for medical use in the United States in 2016 and Europe in 2020. While approved in the United Kingdom and Europe, it is not available their as of 2021. In the United States it is kept in the Strategic National Stockpile.